120 results
Page 5 of 6
6-K
lwe5tkl 83m
15 Jan 20
Current report (foreign)
8:35pm
6-K
EX-99.1
rsb 7xdl3hb
10 Dec 19
ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix
12:00am
6-K
EX-99.3
ktcooex xh
7 Nov 19
Current report (foreign)
9:11am
6-K
EX-99.2
l88is8
7 Nov 19
Current report (foreign)
9:11am
6-K
EX-99.1
p6hz5szpwqgyrx
31 Oct 19
ObsEva Announces Clearance to Initiate Pivotal US Phase 3 Clinical
4:21pm
6-K
EX-99.1
4ahq9
12 Sep 19
ObsEva announces new composition of its Executive Committee
8:16am
6-K
EX-99.1
x7m0rw b9hv5icfbo
6 Sep 19
ObsEva Reports New Clinical Evidence of Nolasiban Mechanism of
8:27am
F-3
EX-4.2
jb8twa eq
7 Aug 19
Shelf registration (foreign)
8:24am
6-K
EX-99.1
ejk ya5kqqyzxhi
7 Aug 19
Current report (foreign)
7:21am
6-K
EX-99.3
d8i38p
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
3gl465 35obuq1h3
5 Jul 19
Current report (foreign)
6:01pm
6-K
umcp6 reihqdoyy33v8
19 Jun 19
Current report (foreign)
4:30pm
6-K
EX-99.3
apmufrj8 yw9levtlc
9 May 19
Index to Unaudited Condensed Consolidated Financial Statements
6:05am
6-K
EX-99.3
abw9j o970
8 Nov 18
Index to Unaudited Condensed Consolidated Financial Statements
9:28am
6-K
7sk3iyo728jxzti3eb8j
9 Oct 18
Current report (foreign)
4:42pm
6-K
k85kv2 lyhark
3 Oct 18
Current report (foreign)
9:07am
6-K
ehxojia5 r1p
28 Sep 18
Current report (foreign)
8:40am